Page last updated: 2024-08-24

telmisartan and Arterial Diseases, Carotid

telmisartan has been researched along with Arterial Diseases, Carotid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diao, Y; Liu, Z; Lu, F; Qi, Z; Song, H; Wei, F; Ye, L; Zhang, H; Zhao, Y	1
Jin, D; Kirimura, K; Mino, Y; Miyazaki, M; Muramatsu, M; Takai, S; Yoshikawa, K	1
Yusuf, S	1

Reviews

1 review(s) available for telmisartan and Arterial Diseases, Carotid

Article	Year
From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis. The American journal of cardiology, 2002, Jan-24, Volume: 89, Issue:2A Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Carotid Artery Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left	2002

Article

Year

From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis.

The American journal of cardiology, 2002, Jan-24, Volume: 89, Issue:2A

Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Carotid Artery Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left

2002

Trials

1 trial(s) available for telmisartan and Arterial Diseases, Carotid

Article	Year
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis, 2014, Volume: 233, Issue:1 Topics: Adult; Aged; Benzimidazoles; Benzoates; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hypertension; Male; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes, Regulatory; Telmisartan; Th17 Cells	2014

Article

Year

Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.

Atherosclerosis, 2014, Volume: 233, Issue:1

Topics: Adult; Aged; Benzimidazoles; Benzoates; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hypertension; Male; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes, Regulatory; Telmisartan; Th17 Cells

2014

Other Studies

1 other study(ies) available for telmisartan and Arterial Diseases, Carotid

Article	Year
Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Carotid Artery Diseases; Gene Expression; Hypertension; Immunohistochemistry; Lipids; Losartan; Male; Membrane Transport Proteins; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Organ Size; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Vasodilation	2005

Article

Year

Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.

Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:7

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Carotid Artery Diseases; Gene Expression; Hypertension; Immunohistochemistry; Lipids; Losartan; Male; Membrane Transport Proteins; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Organ Size; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Vasodilation

2005